EUVIMEDEUVIMED entdecken
Fallbericht

Aberrant GATA3 reactivity in a clear cell renal cell carcinoma with clear cell papillary renal cell tumor-like features: a case report

Miruna C Popescu, Mahmut Akgul, Sean R Williamson, Ankur R Sangoi

Virchows Archiv · 2026

DOI: 10.1007/s00428-026-04538-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Virchows Archiv, 2026. Verfasst von Miruna C Popescu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, RKH Hospital, Ludwigsburg, Germany. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell papillary renal cell tumor (CCPRCT) has been reclassified from "carcinoma" to "tumor" in the latest World Health Organization (WHO) Classification in 2022 to better reflect its excellent outcome. Therefore, its distinction from its closest mimic, clear cell renal cell carcinoma (CCRCC), is now more clinically relevant than ever. The well-documented occurrence of tumors with significant overlapping morphologic and immunohistochemical features between CCPRCT and CCRCC has sparked a search for additional immunohistochemical markers that may aid in this distinction. Based on the putative distal nephron origin of CCPRCT, GATA binding protein 3 (GATA3) has been proposed as a sensitive and specific marker for this diagnosis, with only exceptional cases of CCRCC reported to show GATA3 reactivity. To the best of our knowledge, this is the first report of a molecularly-confirmed, low-stage, low-grade CCRCC showing overlapping histology with CCPRCT and an exceptional CCPRCT-like immunohistochemical profile, including diffuse nuclear expression of GATA3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GATA3 Transcription FactorCarcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorHumansImmunohistochemistryCarcinoma, PapillaryMale

Stichwörter der Autor:innen

AberrantBorderline featuresClear cell papillary renal cell tumorClear cell renal cell carcinomaGATA3Overlap

Substanzen

GATA3 Transcription FactorGATA3 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute of Pathology, RKH Hospital, Ludwigsburg, Germany.
  • Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Department of Pathology, Stanford Medical Center, Stanford Hospital, 300 Pasteur Drive, Stanford, CA, 94305, USA. asangoi@stanford.edu.

Zitieren

APA

Popescu, M. C., Akgul, M., Williamson, S. R., & Sangoi, A. R. (2026). Aberrant GATA3 reactivity in a clear cell renal cell carcinoma with clear cell papillary renal cell tumor-like features: a case report. Virchows Archiv. https://doi.org/10.1007/s00428-026-04538-7

Vancouver

Popescu MC, Akgul M, Williamson SR, Sangoi AR. Aberrant GATA3 reactivity in a clear cell renal cell carcinoma with clear cell papillary renal cell tumor-like features: a case report. Virchows Archiv. 2026. doi:10.1007/s00428-026-04538-7

BibTeX
@article{Popescu2026,
  author = {Popescu, Miruna C and Akgul, Mahmut and Williamson, Sean R and Sangoi, Ankur R},
  title = {Aberrant GATA3 reactivity in a clear cell renal cell carcinoma with clear cell papillary renal cell tumor-like features: a case report},
  journal = {Virchows Archiv},
  year = {2026},
  doi = {10.1007/s00428-026-04538-7}
}
Kostenlos starten →